Acceder

Bibliografías temáticas / Prevention of thrombosis / Artículos de revistas

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Prevention of thrombosis.

Artículos de revistas sobre el tema "Prevention of thrombosis"

Autor: Grafiati

Publicado: 7 de junio de 2025

Última modificación: 2 de agosto de 2025

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Prevention of thrombosis".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Rudnicka, Alicja R., Deborah Ashby, Patrick Brennan, and Tom Meade. "Thrombosis Prevention Trial." Archives of Internal Medicine 163, no. 12 (2003): 1454. http://dx.doi.org/10.1001/archinte.163.12.1454.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

Strijkers, Rob HW, Mark AF de Wolf, and Cees HA Wittens. "Risk factors of postthrombotic syndrome before and after deep venous thrombosis treatment." Phlebology: The Journal of Venous Disease 32, no. 6 (2016): 384–89. http://dx.doi.org/10.1177/0268355516652010.

Texto completo

Resumen

Postthrombotic syndrome is the most common complication after deep venous thrombosis. Postthrombotic syndrome is a debilitating disease and associated with decreased quality of life and high healthcare costs. Postthrombotic syndrome is a chronic disease, and causative treatment options are limited. Prevention of postthrombotic syndrome is therefore very important. Not all patients develop postthrombotic syndrome. Risk factors have been identified to try to predict the risk of developing postthrombotic syndrome. Age, gender, and recurrent deep venous thrombosis are factors that cannot be change

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Silleran-Chassany, J., and D. Safran. "Prophylaxis of Perioperative Venous Thrombosis: Role of Venous Compression." Phlebology: The Journal of Venous Disease 15, no. 3-4 (2000): 138–42. http://dx.doi.org/10.1177/026835550001500311.

Texto completo

Resumen

Aim: To review the role of compression treatments in the prevention of perioperative deep venous thrombosis. Method: A review of current literature in the field of prevention of deep venous thrombosis following general and orthopaedic surgery has been conducted. Synthesis: There is a considerable risk of deep venous thrombosis following surgical treatment in hospital. This is particularly high following joint replacement in the lower limb. This may lead to fatal pulmonary embolism or chronic venous insufficiency of the lower limb with leg ulceration and disability. Perioperative deep venous th

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Cancer, Susana, Salvador Luján, and Enrique Puras. "Intraoperative Venous Balloon Angioplasty during Surgical Thoracic Outlet Decompression in Paget-Schrötter Syndrome." Vascular 12, no. 2 (2004): 136–39. http://dx.doi.org/10.1258/rsmvasc.12.2.136.

Texto completo

Resumen

The management of primary subclavian-axillary vein thrombosis is controversial. Indications and time of operative or endovascular intervention after successful thrombolysis remain unresolved. To improve the long-term functional outcomes in patients with primary subclavian-axillary vein thrombosis, early reestablishment of venous patency and prevention of recurrent thrombosis are required. We present a case in which, after catheter-directed thrombolysis, positional venography showed costoclavicular compression of the subclavian vein. At the time of surgical thoracic outlet decompression, transl

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Damjanović, Miodrag, Milan Pavlović, Svetlana Apostolović, et al. "Prevention of stent thrombosis." Srce i krvni sudovi 33, no. 2 (2014): 123–27. http://dx.doi.org/10.5937/siks1402123d.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Atchabahian, Arthur, and Alain C. Masquelet. "Experimental prevention of free flap thrombosis. II: Normovolemic hemodilution for thrombosis prevention." Microsurgery 17, no. 12 (1996): 714–16. http://dx.doi.org/10.1002/(sici)1098-2752(1996)17:12<714::aid-micr10>3.0.co;2-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Bezlepkin, Yu A., I. N. Sonkin, A. V. Gusinskiy, et al. "COMPARISON OF LONG-TERM RESULTS OF FEMORAL VEIN LIGATION AND TRANSCATHETER THROMBOLYSIS IN THROMBOSIS OF THE FEMORAL SEGMENT." Grekov's Bulletin of Surgery 178, no. 5 (2019): 62–68. http://dx.doi.org/10.24884/0042-4625-2019-178-5-62-68.

Texto completo

Resumen

INTRODUCTION. The problem of preventing massive pulmonary thromboembolism and post-thrombotic syndrome in deep vein thrombosis has been studied for a long period. The introduction of new treatments for deep vein thrombosis requires a detailed comparison of their effectiveness.The OBJECTIVE of this work was a comparative analysis of ligation of the superficial femoral vein and regional thrombolytic therapy.MATERIAL AND METHODS. A retrospective multicenter study involving 30 patients with femoproplite thrombosis, who had received catheter-directed thrombolysis or ligation of the superficial femo

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Lim, Wendy. "Prevention of thrombosis in antiphospholipid syndrome." Hematology 2016, no. 1 (2016): 707–13. http://dx.doi.org/10.1182/asheducation-2016.1.707.

Texto completo

Resumen

Abstract Antiphospholipid syndrome (APS) is an acquired autoimmune condition characterized by thrombotic events, pregnancy morbidity, and laboratory evidence of antiphospholipid antibodies (aPL). Management of these patients includes the prevention of a first thrombotic episode in at-risk patients (primary prevention) and preventing recurrent thrombotic complications in patients with a history of thrombosis (secondary prevention). Assessment of thrombotic risk in these patients, balanced against estimated bleeding risks associated with antithrombotic therapy could assist clinicians in determin

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

Zhang, Ning, Yuan Xu, Qiao-Dan Lu, et al. "Nurses’ knowledge, attitude, and practice in peripherally inserted central catheter-related thrombosis prophylactic practices: A multicentric cross-sectional study." Medicine 104, no. 17 (2025): e42005. https://doi.org/10.1097/md.0000000000042005.

Texto completo

Resumen

Peripherally inserted central catheter (PICC)-related thrombosis is preventable, and nurses play a play a crucial role in its prevention. The implementation of nurses’ preventive practice is key to reducing the occurrence of PICC-related thrombosis. The level of nurses’ knowledge, attitude, and practice can influence the prevention of PICC-related thrombosis, which is important for reducing patient suffering. The aim of this study was to assess nurses’ knowledge, attitude, and practice level regarding PICC-related thrombosis prevention based on evidence-based guidelines. Data were collected us

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Duval, Cédric. "Fibrinogen levels and thrombosis prevention." Blood 139, no. 9 (2022): 1269–71. http://dx.doi.org/10.1182/blood.2021015051.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Matthews, Hugh. "Prevention of hospital-acquired thrombosis." British Journal of General Practice 66, no. 652 (2016): 559.1–559. http://dx.doi.org/10.3399/bjgp16x687709.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Tai, Ming-Wai, and Burgunda V. Sweet. "Nattokinase for prevention of thrombosis." American Journal of Health-System Pharmacy 63, no. 12 (2006): 1121–23. http://dx.doi.org/10.2146/ajhp050509.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Verstraete, M. "Prevention of Thrombosis in Arteries." Journal of Cardiovascular Pharmacology 7 (1985): S191—S205. http://dx.doi.org/10.1097/00005344-198500073-00023.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Gough, N. R. "Thrombosis Prevention Without Bleeding Extension." Science Signaling 6, no. 301 (2013): ec276-ec276. http://dx.doi.org/10.1126/scisignal.2004896.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Vaidya, Jayant S. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1204. http://dx.doi.org/10.1016/s0140-6736(98)26016-8.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Fahey, Tom, and Tim J. Peters. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1204–5. http://dx.doi.org/10.1016/s0140-6736(05)79150-9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

lacoviello, Licia, and Maria Benedetta Donati. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1205. http://dx.doi.org/10.1016/s0140-6736(05)79151-0.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

Jolobe, OMP. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1205. http://dx.doi.org/10.1016/s0140-6736(05)79152-2.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Cleland, John GF, and Ian Ford. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1205–6. http://dx.doi.org/10.1016/s0140-6736(05)79153-4.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Peverill, Roger E., Richard W. Harper, and Joseph J. Smolich. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1206. http://dx.doi.org/10.1016/s0140-6736(05)79154-6.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

FitzGerald, Garret A., and William N. Charman. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1206. http://dx.doi.org/10.1016/s0140-6736(05)79155-8.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Meade, TW, and PJ Brennan. "Interpretation of Thrombosis Prevention Trial." Lancet 351, no. 9110 (1998): 1206–7. http://dx.doi.org/10.1016/s0140-6736(05)79156-x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Crunkhorn, Sarah. "Safe path to thrombosis prevention." Nature Reviews Drug Discovery 16, no. 3 (2017): 164–65. http://dx.doi.org/10.1038/nrd.2017.27.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

P, Rajendra Kumar Jain, and Nishad Chitnis. "Stent thrombosis: Prevention and management." Journal of Medical and Scientific Research 2, no. 1 (2014): 5–12. http://dx.doi.org/10.17727/jmsr.2014/2-001.

Texto completo

Resumen

Stent thrombosis (ST) is a persistent and important clinical problem. Stent thrombosis has been defined and classified by the Academic Research Consortium (ARC). We have reviewed the data available on the incidence of ST in various registries and trials. The incidence of ST is higher with DES compared to BMS. ST incidence is highest with first generation DES but reduces significantly with second and third generation DES. We have reviewed the factors which predict a higher incidence of ST. These can be divided into patient, lesion and procedure characteristics. The upcoming new technologies and

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Lee, Hannah, Sharelle Sturgeon, Shaun Jackson, and Justin Hamilton. "The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions." Thrombosis and Haemostasis 107, no. 02 (2012): 328–37. http://dx.doi.org/10.1160/th11-06-0418.

Texto completo

Resumen

SummaryDeveloping novel anti-platelet therapies is an important clinical strategy for the prevention of arterial thromboses which cause heart attacks and most strokes. Thrombin activates platelets via protease-activated receptors (PARs), and PAR antagonists are currently under investigation as antithrombotics. Yet despite these clinical advances, the importance of PARs to platelet activation during thromboses formed under pathological conditions has not been investigated. To this end, we examined the role of PAR-dependent platelet activation in thrombus formation in the presence of elevated bl

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Melnikov, A. P., E. I. Moskovkina, and K. S. Gasanova. "Prevention of thrombosis in gynecological oncology." Clinical Medicine (Russian Journal) 102, no. 11-12 (2025): 824–30. https://doi.org/10.30629/0023-2149-2024-102-11-12-824-830.

Texto completo

Resumen

This review of foreign literature addresses the pressing issue of preventing venous thromboembolic complications in the practice of modern oncogynecologists. It emphasizes the connection between the severity of the oncological process and the frequency of thromboembolic complications, the presence of which predetermines an unfavorable outcome. The review discusses methods for the prophylactic use of anticoagulants, their role in comprehensive therapy, and their interaction with other treatment methods. This work also discusses laboratory techniques for determining markers of oncological diseas

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Silva Marques, João, and Cristina Gonçalves. "Post-catheterisation arterial thrombosis in children – pathophysiology, prevention, and treatment." Cardiology in the Young 24, no. 5 (2014): 767–73. http://dx.doi.org/10.1017/s1047951114000171.

Texto completo

Resumen

AbstractLower limb ischaemia is the most frequent complication of cardiac catheterisation in children. It is often overlooked, but it can cause significant disability and may limit arterial access sites to repeat diagnostic or interventional catheterisations. A narrative review of the literature on arterial access site thrombosis in children was carried out with a special focus on current evidence that supports preventive and treatment strategies. Anticoagulation, thrombolysis, and thrombectomy have been used successfully to treat arterial access site thrombosis. However, it is not completely

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Borzdova, Anastasiya, Diana Bekova, Niqar Alieva, Vladimir Ochirov, and Rashid Soliev. "Surgical Prevention of Thrombosis in Modern Condition." Journal of Complementary Medicine Research 14, no. 1 (2023): 117. http://dx.doi.org/10.5455/jcmr.2023.14.01.22.

Texto completo

Resumen

The article discusses the features of surgical prevention of thrombosis in modern conditions. The author notes that due to the high risk of death, thrombosis that occurs during surgical interventions of various types have a significant impact on the quality of medical care in the surgical environment. Accordingly, it is very important to determine the risk of postoperative venous thromboembolism and evaluate the features of its prevention. A particular risk is the development of venous thromboembolism (VTE), which combines deep vein thrombosis (DVT) and pulmonary embolism (PE). Experts call it

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Popovich, Yaroslav M., Vyacheslav V. Korsak, Patricia O. Boldizhar, and Orest P. Laver. "Surgical Prevention of Thromboembolic Complications in Transfascial Thrombosis." Ukrainian Journal of Cardiovascular Surgery 31, no. 1 (2023): 66–73. http://dx.doi.org/10.30702/ujcvs/23.31(01)/pk002-6673.

Texto completo

Resumen

The aim. To evaluate the effectiveness of surgical methods of prevention of venous thromboembolic complications in transfascial thrombosis of the lower extremities. Materials and methods. The paper analyzes the results of examination and surgical or conservative treatment of 417 patients with transfascial thrombosis treated at the Vascular Surgery Department of the Zakarpattia Regional Clinical Hospital named after A. Novak from 1995 to March 2020 and at the Surgical Department of the Central City Clinical Hospital of Uzhhorod from September 2020 to September 2022. The main (I) group con

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Yohannes, Senay, Tarkie Abebe, Kidist Endalkachew, and Destaw Endeshaw. "Nurses’ Knowledge, Perceived Practice, and their Associated Factors regarding Deep Venous Thrombosis (DVT) Prevention in Amhara Region Comprehensive Specialized Hospitals, Northwest Ethiopia, 2021: A Cross-Sectional Study." Critical Care Research and Practice 2022 (March 16, 2022): 1–9. http://dx.doi.org/10.1155/2022/7386597.

Texto completo

Resumen

Introduction. Deep venous thrombosis is a preventable and treatable cause of death among hospitalized patients. Nurses’ knowledge and proper assessment can play a major role in improving deep venous thrombosis prevention care. Objective. To assess the knowledge, practice, and associated factors towards deep venous thrombosis prevention among nurses working at Amhara region hospitals. Methods. Institutional-based cross-sectional study was conducted among nurses working at Amhara region comprehensive specialized hospitals, Northwest, Ethiopia, from April 1 to 30, 2021. A simple random sampling t

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Jacobson, B. F. "Thrombosis - prevention is better than cure." South African Medical Journal 103, no. 4 (2013): 231. http://dx.doi.org/10.7196/samj.6808.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Gallus, A. S. "Prevention of deep leg vein thrombosis." Australian Prescriber 21, no. 2 (1998): 37–39. http://dx.doi.org/10.18773/austprescr.1998.030.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

Brose, Kelsey. "Cancer-Associated Thrombosis: Prevention and Treatment." Current Oncology 15, S1 (2008): 58–67. http://dx.doi.org/10.3747/co.2008.177.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Davies, Mark G. "Deep Venous Thrombosis: Prevention and Treatment." Methodist DeBakey Cardiovascular Journal 5, no. 4 (2009): 25. http://dx.doi.org/10.14797/mdcvj.179.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Nicolaides, AndrewN. "Prevention of recurrent deep-vein thrombosis." Vascular Investigation and Therapy 2, no. 1 (2019): 19. http://dx.doi.org/10.4103/vit.vit_8_19.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Colwell, Clifford W., Mark I. Froimson, Michael A. Mont, et al. "Thrombosis Prevention After Total Hip Arthroplasty." Journal of Bone and Joint Surgery-American Volume 92, no. 3 (2010): 527–35. http://dx.doi.org/10.2106/jbjs.i.00047.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Swierstra, Bart, Jeanne Stibbe, and Hubert Schouten. "Prevention of thrombosis after hip arthroplasty." Acta Orthopaedica 59, no. 2 (1988): 139–43. http://dx.doi.org/10.3109/17453678809169694.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Lowe, Gordon D. O. "Measurement of thrombosis and its prevention." British Journal of Clinical Pharmacology 54, no. 1 (2002): 96–100. http://dx.doi.org/10.1046/j.1365-2125.2002.01626.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Vinchi, Francesca. "Thrombosis Prevention: Let's Drug the Microbiome!" HemaSphere 3, no. 1 (2019): e165. http://dx.doi.org/10.1097/hs9.0000000000000165.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Eriksson, Mats, Kjeld Christensen, Tomas L. Lindahl, and Anders Larsson. "Pharmaceutical thrombosis prevention in cardiovascular disease." Expert Opinion on Investigational Drugs 11, no. 4 (2002): 553–63. http://dx.doi.org/10.1517/13543784.11.4.553.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

Kakkar, V. V. "Prevention and management of venous thrombosis." British Medical Bulletin 50, no. 4 (1994): 871–903. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072931.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Swierstra, Bart A., Jeanne Stibbe, and Hubert J. A. Schouten. "Prevention of thrombosis after hip arthroplasty." Acta Orthopaedica Scandinavica 59, no. 2 (1988): 139–43. http://dx.doi.org/10.1080/17453678809169694.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Davies, Mark G. "Deep Venous Thrombosis: Prevention And Treatment." Methodist DeBakey Cardiovascular Journal 5, no. 4 (2009): 25–31. http://dx.doi.org/10.14797/mdcj-5-4-25.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Lekstrom, Julie A., and William R. Bell. "Aspirin in the Prevention of Thrombosis." Medicine 70, no. 3 (1991): 161–78. http://dx.doi.org/10.1097/00005792-199105000-00001.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

PLUMLEY, P. "PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSIS." Lancet 328, no. 8509 (1986): 750. http://dx.doi.org/10.1016/s0140-6736(86)90268-0.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Bounameaux, H., and B. Krahenbuhl. "PREVENTION OF POSTOPERATIVE DEEP VEIN THROMBOSIS." Lancet 328, no. 8504 (1986): 456. http://dx.doi.org/10.1016/s0140-6736(86)92157-4.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Uldall, Robert. "Prevention of Thrombosis in Arteriovenous Fistulas." Blood Purification 3, no. 1-3 (1985): 89–93. http://dx.doi.org/10.1159/000169401.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Chard, Robin. "Perioperative prevention of deep vein thrombosis." AORN Journal 90, no. 1 (2009): 119–20. http://dx.doi.org/10.1016/j.aorn.2009.06.010.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

Browse, N. L. "Prevention of postoperative deep vein thrombosis." British Journal of Surgery 75, no. 9 (1988): 835–36. http://dx.doi.org/10.1002/bjs.1800750903.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

Cate-Hoek, A. J. Ten, M. H. Prins, C. H. A. Wittens, and H. Ten Cate. "Postintervention duration of anticoagulation in venous surgery." Phlebology: The Journal of Venous Disease 28, no. 1_suppl (2013): 105–11. http://dx.doi.org/10.1177/0268355513476415.

Texto completo

Resumen

For a substantial proportion of patients with deep venous thrombosis (DVT), current treatment strategies are suboptimal and new treatment options are needed. Especially for the group of patients who are at the highest risk for post-thrombotic syndrome, new treatment modalities such as catheter-directed thrombolysis and additional stenting are being investigated. With current clinical studies addressing new technical options, the medical management of patients following these interventions deserves attention. The duration of anticoagulant treatment following surgical or radiological interventio

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!